Delivery Order SPE2DR25D1053-SPE2DR26FT398
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a contract ceiling value of $13,488.42. This is a firm fixed-price delivery order with no set-aside designation, placing performance at AmerisourceBergen's Conshohocken, Pennsylvania location, and is scheduled for completion by October 30, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,511.11 on November 3, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $2,792.28. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 17, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $64,621.77 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) on September 26, 2025, with completion expected by September 29, 2025. This contract employs firm fixed-price pricing under a non-competitive, non-set-aside arrangement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $20,161.40 to AmerisourceBergen Drug Corp for Ondansetron ODT 4MG tablets (30-count supply) on October 28, 2025, with completion targeted for November 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under a child contract arrangement. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $15,178.69. This is a firm fixed-price, non-set-aside delivery order awarded on May 5, 2025, with an ultimate completion date of May 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 4, 2025, for Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $3,208.01. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. The order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of 500 tablets of Ondansetron HCL 4 mg at a ceiling value of $10,310.45. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 23, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $5,709.71 and an ultimate completion date of August 25, 2025. The contract represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT398Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $12,047.30. This firm fixed-price delivery order, which will be completed by October 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product being delivered—Ondansetron, an antiemetic medication commonly used for nausea and vomiting management—supports military healthcare programs and federal medical supply chain requirements. AmerisourceBergen Drug Corp's extensive portfolio of federal contracts with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement needs across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and medical supplies. The company's role as a prime vendor under the DLA Troop Support Medical contract enables it to serve critical federal customers including the Defense Health Agency and U.S. Coast Guard, maintaining essential pharmaceutical inventory for military personnel and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 10/28/25 |